{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:15:12Z","timestamp":1794705312027,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/20416-5"],"award-info":[{"award-number":["2016\/20416-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3069-x","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:38:21Z","timestamp":1522809501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection"],"prefix":"10.1186","volume":"18","author":[{"given":"Mateus Trinconi","family":"Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"Mur\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Burlamaqui","family":"Klautau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-6024","authenticated-orcid":false,"given":"Mauro Jos\u00e9 Costa","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"3069_CR1","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2106\/00004623-200410000-00028","volume":"86-A","author":"L Lazzarini","year":"2004","unstructured":"Lazzarini L, Mader JT, Cahoun JH. Osteomyelitis in long bones. J Bone Joint Surg. 2004;86-A:2305\u201318.","journal-title":"J Bone Joint Surg"},{"key":"3069_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0002-9610(03)00292-7","volume":"188","author":"B Parsons","year":"2004","unstructured":"Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg. 2004;188:57\u201366.","journal-title":"Am J Surg"},{"issue":"6","key":"3069_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.berh.2006.08.014","volume":"20","author":"IG Sia","year":"2006","unstructured":"Sia IG, Berbari EF. Osteomyelitis. Best Pract Res Clin Rheumatol. 2006;20(6):1065\u201381.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"3069_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12570-011-0056-8","volume":"1","author":"CL Roman\u00f3","year":"2011","unstructured":"Roman\u00f3 CL, Roman\u00f3 D, Logoluso N, et al. Bone and joint infections in adults: a comprehensive classification proposal. Eur Orthop Traumatol. 2011;1(6):207\u201317.","journal-title":"Eur Orthop Traumatol"},{"key":"3069_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/01.bpo.0000242431.91489.b4","volume":"26","author":"SR Arnold","year":"2006","unstructured":"Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26:703\u20138.","journal-title":"J Pediatr Orthop"},{"issue":"9431","key":"3069_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","volume":"364","author":"DP Lew","year":"2004","unstructured":"Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369\u201379.","journal-title":"Lancet"},{"issue":"11","key":"3069_CR7","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1302\/0301-620X.91B11.22026","volume":"91","author":"GS Biring","year":"2009","unstructured":"Biring GS, Kostamo T, Garbuz DS, et al. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. J Bone Joint Surg Br. 2009;91(11):1431\u20137.","journal-title":"J Bone Joint Surg Br"},{"issue":"6","key":"3069_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jac\/47.6.885","volume":"47","author":"D Neut","year":"2001","unstructured":"Neut D, van de Belt H, Stokroos I, et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47(6):885\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"3069_CR9","doi-asserted-by":"crossref","unstructured":"Moojen DJ, Hentenaar B, Charles Vogely H, et al. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplast. 2008:1152\u20136.","DOI":"10.1016\/j.arth.2007.08.020"},{"issue":"12","key":"3069_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/107110070502601216","volume":"26","author":"MW Wong","year":"2005","unstructured":"Wong MW, Hui M. Development of gentamicin resistance after gentamicin-PMMA beads for treatment of foot osteomyelitis: report of two cases. Foot Ankle Int. 2005;26(12):1093\u20135.","journal-title":"Foot Ankle Int"},{"issue":"1","key":"3069_CR11","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1016\/j.actbio.2012.08.023","volume":"9","author":"JR Jones","year":"2013","unstructured":"Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013;9(1):4457\u201386.","journal-title":"Acta Biomater"},{"issue":"6","key":"3069_CR12","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.actbio.2011.03.016","volume":"7","author":"MN Rahaman","year":"2011","unstructured":"Rahaman MN, Day DE, Bal BS, et al. Bioactive glass in tissue engineering. Acta Biomater. 2011;7(6):2355\u201373.","journal-title":"Acta Biomater"},{"issue":"1","key":"3069_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jor.22463","volume":"32","author":"DC Cora\u00e7a-Huber","year":"2014","unstructured":"Cora\u00e7a-Huber DC, Fille M, Hausdorfer J, Putzer D, Nogler M. Efficacy of antibacterial bioactive glass S53P4 against S. Aureus biofilms grown on titanium discs in vitro. J Orthop Res. 2014;32(1):175\u20137.","journal-title":"J Orthop Res"},{"issue":"5","key":"3069_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2217\/fmb.14.20","volume":"9","author":"L Drago","year":"2014","unstructured":"Drago L, Vassena C, Fenu S, et al. In vitro antibiofilm activity of bioactive glass S53P4. Future Microbiol. 2014;9(5):593\u2013601.","journal-title":"Future Microbiol"},{"key":"3069_CR15","doi-asserted-by":"publisher","first-page":"684826","DOI":"10.1155\/2015\/684826","volume":"2015","author":"NAP van Gestel","year":"2015","unstructured":"van Gestel NAP, Geurts J, Hulsen DJW, van Rietbergen B, Hofmann S, Arts JJ. Clinical applications of S53P4 bioactive glass in bone healing and Osteomyelitic treatment: a literature review. Biomed Res Int. 2015;2015:684826.","journal-title":"Biomed Res Int"},{"key":"3069_CR16","volume-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard\u2014eleventh edition. CLSI document M02-A11","author":"CLSI","year":"2012","unstructured":"CLSI. Performance standards for antimicrobial disk susceptibility tests; approved standard\u2014eleventh edition. CLSI document M02-A11. Wayne, PA: Clinical and Laboratory Standards Institute; 2012."},{"issue":"6","key":"3069_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1302\/0301-620X.96B6.33014","volume":"96-B","author":"CL Roman\u00f3","year":"2014","unstructured":"Roman\u00f3 CL, Logoluso N, Meani E, et al. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis. Bone Joint J. 2014;96-B(6):845\u201350.","journal-title":"Bone Joint J"},{"issue":"4","key":"3069_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.7150\/jbji.20404","volume":"2","author":"A Ferrando","year":"2017","unstructured":"Ferrando A, Part J, Baeza J. Treatment of cavitary bone defects in chronic osteomyelitis: biogactive glass S53P4 vs. calcium sulphate antibiotic beads. J Bone Jt Infect. 2017;2(4):194\u2013201.","journal-title":"J Bone Jt Infect"},{"key":"3069_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/5584_2016_156","volume":"971","author":"N Lindfors","year":"2017","unstructured":"Lindfors N, Geurts J, Drago L. Antibacterial bioactive glass, S53P4, for chronic bone infections - a multinational study. Adv Exp Med Biol. 2017;971:81\u201392.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"3069_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1556\/AMicr.61.2014.2.5","volume":"61","author":"I Gergely","year":"2014","unstructured":"Gergely I, Zazgyva A, Man A, et al. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads. Acta Microbiol Immunol Hung. 2014;61(2):145\u201360.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"1","key":"3069_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10856-007-3143-1","volume":"19","author":"E Munukka","year":"2008","unstructured":"Munukka E, Lepp\u00e4ranta O, Korkeam\u00e4ki M, et al. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med. 2008;19(1):27\u201332.","journal-title":"J Mater Sci Mater Med"},{"key":"3069_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/1471-2334-13-584","volume":"13","author":"L Drago","year":"2013","unstructured":"Drago L, Roman\u00f2 D, De Vecchi E, et al. Bioactive glass BAG S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vivo and prospective clinical study. BMC Infect Dis. 2013;13:584.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"3069_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10856-007-3018-5","volume":"19","author":"O Lepp\u00e4ranta","year":"2008","unstructured":"Lepp\u00e4ranta O, Vaahtio M, Peltola T, et al. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vivo. J Mater Sci Mater Med. 2008;19(2):547\u201351.","journal-title":"J Mater Sci Mater Med"},{"issue":"2","key":"3069_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bone.2010.05.030","volume":"47","author":"NC Lindfors","year":"2010","unstructured":"Lindfors NC, Hyv\u00f6nen P, Nyyss\u00f6nen M, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone. 2010;47(2):212\u20138.","journal-title":"Bone"},{"issue":"1","key":"3069_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jac\/dkv327","volume":"71","author":"M Bortolin","year":"2016","unstructured":"Bortolin M, De Vecchi E, Roman\u00f3 CL, et al. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective? J Antimicrob Chemother. 2016;71(1):123\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3069_CR26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2217\/FMB.15.57","volume":"10","author":"L Drago","year":"2015","unstructured":"Drago L, De Vecchi E, Bortolin M, et al. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains. Future Microbiol. 2015;10(8):1293\u20139.","journal-title":"Future Microbiol"},{"issue":"5","key":"3069_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2106\/JBJS.O.00550","volume":"98","author":"M T\u00f8ttrup","year":"2016","unstructured":"T\u00f8ttrup M, Bue M, Koch J, Jensen LK, Hanberg P, Aalb\u00e6k B, et al. Effects of implant-associated osteomyelitis on cefuroxime bone pharmacokinetics: assessment in a porcine model. J Bone Joint Surg Am. 2016;98(5):363\u20139.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"3069_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/infdis\/174.2.414","volume":"174","author":"N Belmatoug","year":"1996","unstructured":"Belmatoug N, Cr\u00e9mieux AC, Bleton R, Volk A, Saleh-Mghir A, Grossin M, et al. A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: a microbiologic, histopathologic, and magnetic resonance imaging characterization. J Infect Dis. 1996;174(2):414\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"3069_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/apm.12597","volume":"125","author":"LK Jensen","year":"2017","unstructured":"Jensen LK, Koch J, Aalb\u00e6k B, Moodley A, Bjarnsholt Y, Kragh KN, Petersen A, Jensen HE. Early implant-associated osteomyelitis results in a peri-implanted bacterial reservoir. APMIS. 2017;125(1):38\u201345.","journal-title":"APMIS"},{"issue":"4","key":"3069_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00004770-200404000-00009","volume":"30","author":"M Zehnder","year":"2004","unstructured":"Zehnder M, S\u00f6derling E, Salonen J, Waltimo T. Preliminary evaluation of bioactive glass S53P4 as an endodontic medication in vitro. J Endod. 2004;30(4):220\u20134.","journal-title":"J Endod"},{"issue":"5","key":"3069_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1085\/jgp.201611699","volume":"149","author":"U \u00c7etiner","year":"2017","unstructured":"\u00c7etiner U, Rowe I, Schams A, Mayhew C, Rubin D, Anishkin A, Sukharev S. Tension-activated channels in the mechanism of osmotic fitness in Pseudomonas aeruginosa. J Gen Physiol. 2017;149(5):595\u2013609.","journal-title":"J Gen Physiol"},{"issue":"1","key":"3069_CR32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/AEM.46.1.152-159.1983","volume":"46","author":"D Le Rudulier","year":"1983","unstructured":"Le Rudulier D, Bouillard L. Glycine betaine, an osmotic effector in Klebsiella pneumoniae and other members of the Enterobacteriaceae. Appl Environ Microbiol. 1983;46(1):152\u20139.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"3069_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2958.2008.06562.x","volume":"71","author":"S Klein","year":"2009","unstructured":"Klein S, Lorenzo C, Hoffmann S, Johannes M, et al. Adaptation of Pseudomonas aeruginosa to various conditions includes tRNA-dependent formation of alanyl-phosphatidylglycerol. Mol Microbiol. 2009;71(3):551\u201365.","journal-title":"Mol Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3069-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T23:47:03Z","timestamp":1604101623000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3069-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3069"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3069-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is approved by the Santa Casa de Sao Paulo Review Board, which waived the need for informed consent for this facility-based retrospective data collection. Since the bacterial strains are not traceable to their respective patients, but only to case details, such as mechanism of the infection, anatomical site and material infected, obtaining informed consent would be virtually impossible.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The laboratory materials for this study were partially funded by Ossis Medical Com\u00e9rcio Importa\u00e7\u00e3o e Exporta\u00e7\u00e3o LTDA (S\u00e3o Paulo, SP, Brazil) and the Bioactive Glass S53P4 samples were provided by BonAlive Biomaterials Ltd. (Turku, Finland).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"157"}}